Sultan 2. Abdülhamid Han Training and Research Hospital, Department of Cardiology, Health Science University, Tibbiye Street, Uskudar, Istanbul, Turkey.
Dr. Siyami Ersek Training and Research Hospital, Department of Cardiology, Health Science University, Istanbul, Turkey.
Heart Lung. 2021 Mar-Apr;50(2):307-312. doi: 10.1016/j.hrtlng.2021.01.006. Epub 2021 Jan 13.
This study examined the possible association between the prognostic nutritional index (PNI) and in-hospital mortality rates in cases with a high cardiovascular risk burden and hospitalized with the diagnosis of coronavirus disease 2019 (COVID-19).
This retrospective and cross-sectional study included 294 COVID-19 patients hospitalized in a tertiary referral pandemic center. The study cohort was grouped into tertiles based on the initial PNI values as T1, T2, and T3. The PNI was calculated for each case and the prognostic value of this index was compared to CURB-65 and 4C mortality risk scores in predicting in-hospital mortality.
Patients stratified into the T1 tertile had a lower lymphocyte count, serum albumin level, and PNI values. In a multivariate analysis, the PNI (OR: 0.688,%95CI: 0.586-0.808, p < 0.001) was an independent predictor for all-cause in-hospital death. After adjusting for confounding independent parameters, patients included in the T1 tertile were found to have 11.2 times higher rates of in-hospital mortality compared to the T3 group, which was presumed as the reference group. In addition, we found that the area under curve (AUC) value of PNI was significantly elevated than that of serum albumin level and total lymphocyte counts alone. [(AUC):0.79 vs AUC:0.75 vs AUC:0.69; respectively).
This study demonstrated that the PNI is independently related with in-hospital mortality in patient with COVID-19 and cardiovascular risk factors. The power of the PNI was also validated using well-accepted risk scores of COVID-19 such as CURB-65 and 4C mortality risk scores.
本研究旨在探讨高心血管风险负担的 COVID-19 患者的预后营养指数(PNI)与住院死亡率之间的可能关联。
本回顾性横断面研究纳入了 294 名在三级转诊大流行中心住院的 COVID-19 患者。根据初始 PNI 值将研究队列分为 T1、T2 和 T3 三分位组。为每个病例计算 PNI,并将该指数的预后价值与 CURB-65 和 4C 死亡风险评分进行比较,以预测住院死亡率。
T1 三分位组的淋巴细胞计数、血清白蛋白水平和 PNI 值较低。在多变量分析中,PNI(OR:0.688,95%CI:0.586-0.808,p < 0.001)是全因住院死亡的独立预测因子。在调整混杂的独立参数后,与 T3 组(假定为参考组)相比,T1 三分位组的住院死亡率高 11.2 倍。此外,我们发现 PNI 的曲线下面积(AUC)值明显高于血清白蛋白水平和总淋巴细胞计数的 AUC 值。[(AUC):0.79 vs AUC:0.75 vs AUC:0.69;分别)。
本研究表明,PNI 与 COVID-19 合并心血管危险因素患者的住院死亡率独立相关。PNI 的效能也通过 CURB-65 和 4C 死亡风险评分等公认的 COVID-19 风险评分得到验证。